Where does JMJ Holdings, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), JMJ Holdings, LLC ranks #19,958 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does JMJ Holdings, LLC hold?

JMJ Holdings, LLC holds 14 US utility patents granted between 2017 and 2025, spanning 2 technology areas.

What is JMJ Holdings, LLC's Innovation Score?

JMJ Holdings, LLC has an Innovation Score of 41.0 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is JMJ Holdings, LLC's patent grant rate increasing or decreasing?

JMJ Holdings, LLC's recent grant velocity is +900% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for JMJ Holdings, LLC's patents?

JMJ Holdings, LLC's patents average 11.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the JMJ Holdings, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

JMJ Holdings, LLC

Q: What technology areas does JMJ Holdings, LLC focus on?

JMJ Holdings, LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 7 patents, ranking #891 of 3,082 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 14 granted patents across 2 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, JMJ ranks #19,958 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 2 technology areas.

#19,958
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.0/100): 11.0
avg claims per patent: +900%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19958 · US Corporation #19,958 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,958/49,997
PHOTO-FINISH Japan Capacitor…
CPC-NARROW A61F · 2 areas
INNOV-PAR 41.0/100
CLAIMS-PAR 11.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +900% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Japan Capacitor Industrial Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How JMJ’s 41.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (23%) Velocity 20.0 pts (49%) Breadth 5.0 pts (12%) Claim depth 6.6 pts (16%)

Qualcomm Incorporated · highest

85
National Dentex · near

41
Tesseract Ventures · near

41
DNF · near

41
JMJ Holdings · this assignee

41
Torqeedo · near

41
3D Lighting… · lowest

7

What this shows JMJ's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for JMJ?

Each dot is one of JMJ’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). JMJ’s own 11.0 claims/patent is ABOVE the 10.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

JMJ vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where JMJ's grants concentrate

JMJ Holdings, LLC is a focused PatentsView assignee: 2 CPC subclasses with 50% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2017. By volume, JMJ sits between Jenax Inc. and Jenoptik Automatisierungstechnik GmbH.

JMJ's three-year grant acceleration

JMJ Holdings, LLC shows 8 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Jenax

14
Jiangsu Dongcheng…

14
Jiangsu Shemar El…

14
JM Energy

14
John Crane

14
Japan Capacitor I…

14
Japan Superconduc…

14
Jenoptik Automati…

14
JMJ Holdings ◀

14

What this shows JMJ holds 14 patents at rank #19,952, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near JMJ

By rank, the assignees closest to #19,952 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in JMJ's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for JMJ, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), JMJ ranks #891 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

DNF Co., Ltd 41 Torqeedo GmbH 41 Tesseract Ventures, LLC 41 National Dentex, LLC 41

JMJ's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

JMJ Holdings, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	7.1%
2021	2	14.3%
2022	4	28.6%
2023	2	14.3%
2024	2	14.3%
2025partial year	3	21.4%

Which technologies does JMJ Holdings, LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 3

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

JMJ Holdings, LLC's patent record in context - here's where to go next.

JMJ Holdings, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 50% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #19,958 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare JMJ Holdings, LLC against Jenax Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.